* Sanara Medtech Inc SMTI.OQ SMTI.O is expected to report
results on November 12.
* The Fort Worth, Texas-based company is expected to report
revenue of $6.3 million, according to the estimate from one
analyst, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Sanara Medtech Inc is
for a loss of 18 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* Wall Street's median 12-month price target for Sanara Medtech
Inc is $45, about 19.6% above its last closing price
of $36.16.
This summary was machine generated November 10 at 21:13 GMT.
All figures in US dollars unless otherwise stated